Clinical Trial Readout Diligence
Doing diligence on clinical trial readouts with our BPIQ team
Reminds me of some important considerations for the likelihood of success:
⇨Prior data for the on-test drug
⇨⇨Same endpoints?
⇨⇨Not available? Then prior trial data for other drugs with the same MOA
⇨Trial design
⇨⇨ Are the characteristics of patients allowed into the trial the same?
⇨⇨⇨ Especially the severity of the disease
⇨⇨How many patients?
⇨⇨How many clinical sites?
& Likelihood of stock move
⇨Market reaction to prior readout
See even more about clinical trial readouts and recent news by following our Twitter feed here: (https://twitter.com/BiopharmIQ)
42 Views